"专家访谈"标签列表

[APASL2014]CEVHAP与终结病毒性肝炎的斗争——陈定信教授访谈2014-03-14

[APASL2014]乙型肝炎疾病进展影响因素知多少——高嘉宏教授访谈2014-03-13

[APASL2014]Mother-to-Infant Transmission of Hepatitis B——Interview with Prof.Ji-Dong Jia2014-03-13

[APASL2014]HBIG Is Being Phased Out!——Interview with Dr.James Fung2014-03-13

[APASL2014]HBV母婴传播阻断百分百：是理想也是奋斗目标——贾继东教授访谈2014-03-13

[APASL2014]Treatment end points of Hepatitis B:What they are and How to achieve?——Interview with Prof.Jia-Horng Kao2014-03-13

[APASL2014]Asia-Pacific Region: The Epicentre of Liver Disease——Interview with Prof.Darrell Crawford2014-03-13

[APASL2014]Encouraging Weight Loss in NAFLD——Interview with Dr.Ingrid Hickman2014-03-13

[APASL2014]亚太地区：肝病流行的“震中”，肝病防控的“砥柱”——Darrell Crawford教授访谈2014-03-13

[APASL2014]鼓励非酒精性脂肪性肝病患者减轻体重——Ingrid Hickman博士访谈2014-03-13

[APASL2014]护士引导的治疗模式的选择——Sue Mason女士访谈2014-03-12

[APASL2014]AHA护理指南的现状与展望——Sally Spruce女士访谈2014-03-12

[APASL2014]为何将巨噬细胞称为“双刃剑”？——Frank Tacke教授访谈2014-03-12

[APASL2014]The Present and Future of AHA Nursing Guidelines——Interview with Sally Spruce2014-03-12

[APASL2014]The Dual Role of Macrophages in Liver Injury——Interview with Prof.Frank Tacke2014-03-12

[APASL2014]New Development of DAA Therapies——Interview with Dr.Michael Beard2014-03-12

[APASL2014]直接抗HCV药物研发现状——Michael Beard教授访谈2014-03-12

[APASL2014]HBIG将退出历史舞台？——James Fung教授访谈2014-03-12

[APASL2014]HBIG Is Being Phased Out!——Interview with Prof.James Fung2014-03-12

[ILCA2013]肝细胞肝癌诊断及预后相关的病理性标志物——香港大学肝脏研究国家重点实验室Irene Oi-Lin NG教授访谈2013-12-20